Intrinsic Value of S&P & Nasdaq Contact Us

Nevro Corp. NVRO NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
45/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$30.32
+419.2%

Stock Statistics — NVRO

Nevro Corp. (NVRO) has a market capitalization of $224.09M and trades at $5.84. The 52-week range is 3.165-13.3.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.9, Earnings Per Share (EPS) of $-3.06, annual revenue of $408.52M.

The stock has a beta of 0.82, operates in the Healthcare sector.

Trading Data
Current Price$5.84
52-Week Range3.165-13.3
Volume751.5K
Avg Volume (30D)1.3M
Market Cap$224.09M
Beta (1Y)0.82
Company
IPO Date2014-11-06
Employees1,099
CEOKevin R. Thornal
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS64157F1030
CUSIP64157F103
Income (Latest Year)
Revenue$408.52M
Gross Profit$269.53M
EBITDA$-126.23M
Operating Income$-126.23M
Net Income$-113.44M
EPS$-3.06
EPS Diluted$-3.06
Shares Outstanding$37.09M
Balance Sheet (Latest Year)
Total Assets$553.84M
Current Assets$476M
Cash & ST Investments$292.53M
Total Liabilities$322.83M
Total Debt$251.16M
Net Debt$156.62M
Total Equity$231.01M
Debt / Equity1.09
Valuation Ratios
P/E Ratio-1.9
P/S Ratio0.55
P/B Ratio0.97
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message